The next question is one that was in front of the U.K. committee. You noted that, and I quote, “If you can bill as several different companies but it is the same team working on it, the paperwork looks compliant even if the project is not.”
To your knowledge, were there any discussions between SCL and/or Cambridge Analytica with AIQ regarding the intentional flouting or circumvention of domestic laws or any sort of expenditure-related rules, and if so, what was the nature of those discussions?